Recent advances in protein metalation: structural studies

Antonello Merlino

Chem. Commun., 2021, 57, 1295
DOI: 10.1039/D0CC08053E

Protein modification by thiolactone homocysteine chemistry: a multifunctionalized human serum albumin theranostic

Tatyana V. Popova, Olesya A. Krumkacheva, Anna S. Burmakova, Anna S. Spitsyna, Olga D. Zakharova, Vladimir A. Lisitskiy, Igor A. Kirilyuk, Vladimir N. Silnikov, Michael K. Bowman, Elena G. Bagryanskaya and Tatyana S. Godovikova

RSC Med. Chem., 2020, 11, 1314
DOI: 10.1039/C9MD00516A

Strategies to expand peptide functionality through hybridisation with a small molecule component

Yuteng Wu, Jack Williams, Ewen D. D. Calder and Louise J. Walport

RSC Chem. Biol., 2021, 2, 151
DOI: 10.1039/D0CB00167H

Crystal structure of human serum albumin in complex with megabody reveals unique human and murine cross‐reactive binding site

Sofia De Felice, Zhanna Romanyuk, Monica Chinellato, Giulia Zoia, Sara Linciano, Yoichi Kumada, Els Pardon, Jan Steyaert, Alessandro Angelini and Laura Cendron

Protein Science, 2024, 33
DOI: 10.1002/pro.4887

Discovery of a Long-Acting Parathyroid Hormone 1–34 Analogue to Treat Hypoparathyroidism

Sida Ruan, Guiying Yang, Yuanzhen Dong, Wenwen Shangguan and Weigen Lu

Mol. Pharmaceutics, 2021, 18, 3260
DOI: 10.1021/acs.molpharmaceut.1c00149

Quantitative cross-species comparison of serum albumin binding of per- and polyfluoroalkyl substances from five structural classes

Hannah M Starnes, Thomas W Jackson, Kylie D Rock and Scott M Belcher

Toxicological Sciences, 2024, 199, 132
DOI: 10.1093/toxsci/kfae028

How Different Albumin-Binders Drive Probe Distribution of Fluorescent RGD Mimetics

Carsten Höltke, Wael Alsibai, Martin Grewer, Miriam Stölting, Christiane Geyer, Michel Eisenblätter, Moritz Wildgruber and Anne Helfen

Front. Chem., 2021, 9
DOI: 10.3389/fchem.2021.689850

Application of the Chelator-Based Clickable Radiotheranostic Platform to Moderate-Molecular-Weight Ligands

Kazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe and Masahiro Ono

ACS Med. Chem. Lett., 2022, 13, 1642
DOI: 10.1021/acsmedchemlett.2c00320

Synthesis and labeling of p-NH2-Bn-DTPA-(Dabcyl-Lys6,Phe7)-pHBSP with 99mTc as a radiopeptide scintigraphic agent to detect cardiac ischemia

Naser Mohtavinejad, Ahmad Bitarafan-Rajabi, Mehdi Shafiee Ardestani, Amir Darbandi-Azar, Ali Khalaj, Atefe Ghodrati, Mehdi Asadi and Massoud Amanlou

J Radioanal Nucl Chem, 2020, 324, 635
DOI: 10.1007/s10967-020-07123-7

Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies

Ahil N. Ganesh, Carolyn Heusser, Sudhakar Garad and Manuel Vicente Sánchez-Félix

Medicine in Drug Discovery, 2021, 9, 100079
DOI: 10.1016/j.medidd.2020.100079

Versatile albumin as a booster to optimize the excited state energy redistribution in photosensitizers enabling fluorescence imaging-guided photodynamic therapy

Ting Wang, Lixin Ma, Yingcui Bu, Xinjie Xu, Xuan Zhao, Yingyong Ni, Qitao Zhao, Zhou Lu, Fei Ge and Hongping Zhou

Chemical Engineering Journal, 2025, 515, 163896
DOI: 10.1016/j.cej.2025.163896

Metabolic phenotyping combined with transcriptomics metadata fortifies the diagnosis of early-stage Hepatocellular carcinoma

Sun Jo Kim, Cheol Woon Jung, Nguyen Hoang Anh, Young Cheol Yoon, Nguyen Phuoc Long, Soon-Sun Hong, Eun Ju Cho and Sung Won Kwon

Journal of Advanced Research, 2025, 74, 153
DOI: 10.1016/j.jare.2024.09.007

Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective

Yao Zhang, Yibing Wang and Junli Liu

Genes & Diseases, 2023, 10, 825
DOI: 10.1016/j.gendis.2021.12.011

Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension

Emma von Witting, Sarah Lindbo, Magnus Lundqvist, Marit Möller, Andreas Wisniewski, Sara Kanje, Johan Rockberg, Hanna Tegel, Mikael Åstrand, Mathias Uhlén and Sophia Hober

Mol. Pharmaceutics, 2021, 18, 328
DOI: 10.1021/acs.molpharmaceut.0c00975

Mathematical model for treatment of neonatal hyperbilirubinemia

DongMei Li, Rui-xue Zhang, Qian Xie and Qi Wang

MBE, 2021, 18, 8758
DOI: 10.3934/mbe.2021432

Deciphering albumin-directed drug delivery by imaging

Huiyu Hu, Jeremy Quintana, Ralph Weissleder, Sareh Parangi and Miles Miller

Advanced Drug Delivery Reviews, 2022, 185, 114237
DOI: 10.1016/j.addr.2022.114237

Model-Based Analysis of IGF-I Response, Dosing, and Monitoring for Once-Weekly Somapacitan in Children With GH Deficiency

Rasmus J Kildemoes, Philippe F Backeljauw, Michael Højby, Joanne C Blair, Bradley S Miller, Jun Mori and Yassine K Lyauk

Journal of the Endocrine Society, 2023, 7
DOI: 10.1210/jendso/bvad115

Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitor

Tsutomu Takeuchi

Modern Rheumatology, 2023, 33, 1059
DOI: 10.1093/mr/road038

Injectables and Depots to Prolong Drug Action of Proteins and Peptides

Nkiruka Ibeanu, Raphael Egbu, Lesley Onyekuru, Hoda Javaheri, Peng Tee Khaw, Gareth R. Williams, Steve Brocchini and Sahar Awwad

Pharmaceutics, 2020, 12, 999
DOI: 10.3390/pharmaceutics12100999

Mirror-Image Human Serum Albumin Domain III as a Tool for Analyzing Site II-Dependent Molecular Recognition

Naoya Iwamoto, Takuma Kai, Shinsuke Inuki, Hiroaki Ohno, Hitoshi Maeda, Hiroshi Watanabe, Toru Maruyama and Shinya Oishi

Bioconjugate Chem., 2024, 35, 816
DOI: 10.1021/acs.bioconjchem.4c00150

Spectrofluorimetric analysis of the binding of a target molecule to serum albumin: tricky aspects and tips

Francesca Macii and Tarita Biver

Journal of Inorganic Biochemistry, 2021, 216, 111305
DOI: 10.1016/j.jinorgbio.2020.111305

Metasurface Platform Incorporating Aggregation Induced Emission Based Biosensor for Enhanced Human Serum Albumin Detection

Qi Hu, Masanobu Iwanaga and Youhong Tang

Advanced Optical Materials, 2024, 12
DOI: 10.1002/adom.202400868

A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders

Xinxin Gao, Harini Kaluarachchi, Yingnan Zhang, Sunhee Hwang, Rami N. Hannoush and Matteo De March

PLoS ONE, 2024, 19, e0299804
DOI: 10.1371/journal.pone.0299804

Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance

Shiv Pratap S. Yadav, Ruben M. Sandoval, Jingfu Zhao, Yifan Huang, Exing Wang, Sudhanshu Kumar, Silvia B. Campos-Bilderback, George Rhodes, Yehia Mechref, Bruce A. Molitoris and Mark C. Wagner

American Journal of Physiology-Renal Physiology, 2021, 320, F114
DOI: 10.1152/ajprenal.00428.2020

Construction and application of a large capacity VNAR library from the whitespotted bamboo shark (Chiloscyllium playgiosum)

Hao Li, Litong Liu, Xinyi Kang, Chuan-Wei Chen, Mengran Wang, Shaoqin Fu, Qingtong Zhou, Bo Zhao, Dehua Yang and Ming-Wei Wang

Acta Pharmaceutica Sinica B, 2025, 15, 1912
DOI: 10.1016/j.apsb.2025.02.012

Characterization of binding between model protein GA-Z and human serum albumin using asymmetrical flow field-flow fractionation and small angle X-ray scattering

Jaeyeong Choi, Marie Wahlgren, Vilhelm Ek, Ulla Elofsson, Jonas Fransson, Lars Nilsson, Ann Terry, Christopher A. G. Söderberg and Rajagopal Subramanyam

PLoS ONE, 2020, 15, e0242605
DOI: 10.1371/journal.pone.0242605

Albumin Binds Doxorubicin via Self–Assembling Dyes as Specific Polymolecular Ligands

Anna Jagusiak, Katarzyna Chłopaś, Grzegorz Zemanek, Izabela Kościk, Paweł Skorek and Barbara Stopa

IJMS, 2022, 23, 5033
DOI: 10.3390/ijms23095033

Nanobodies: Robust miniprotein binders in biomedicine

Jeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, Zhuolun Shen and Yi Shi

Advanced Drug Delivery Reviews, 2023, 195, 114726
DOI: 10.1016/j.addr.2023.114726

Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics

Srikanth Boinapally, Suresh Alati, Zirui Jiang, Yu Yan, Alla Lisok, Rajan Singh, Gabriela Lofland, Il Minn, Robert F. Hobbs, Martin G. Pomper and Sangeeta Ray Banerjee

Molecules, 2023, 28, 6158
DOI: 10.3390/molecules28166158

Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines

Muhetaerjiang Mamuti, Weizhi Chen and Xiqun Jiang

Advanced NanoBiomed Research, 2023, 3
DOI: 10.1002/anbr.202200080

Thermal effects and drugs competition on the palmitate binding capacity of human serum albumin

Rita Guzzi and Rosa Bartucci

Biochemical and Biophysical Research Communications, 2024, 722, 150168
DOI: 10.1016/j.bbrc.2024.150168

A fatty acid modification strategy to improve the binding affinity of Epirubicin to human serum albumin for efficient cancer therapy

Minglong Huang, Xin Wang, Jialin Xing, Bowen Zhang, Lurong Zhang, Yaqiao Li, Hongying Xiao, Qing Wang, Jun Yuan, Yafan Xiao, Zhenzhen Zhao, Zhonggui He, Lingxiao Li and Bingjun Sun

Chemical Engineering Journal, 2025, 519, 165724
DOI: 10.1016/j.cej.2025.165724

Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders

Keisei Yamaguchi, Nobuki Kazuta, Shohei Tsuchihashi, Hiroyuki Watanabe and Masahiro Ono

Nuclear Medicine and Biology, 2024, 138-139, 108945
DOI: 10.1016/j.nucmedbio.2024.108945

Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain

Marcus Stroet, Erik de Blois, Marion de Jong, Yann Seimbille, Laura Mezzanotte, Clemens Löwik and Kranthi Panth

Cancers, 2022, 14, 861
DOI: 10.3390/cancers14040861

Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models

Wenyu Song, Weijun Wei, Xiaoli Lan and Weibo Cai

Eur J Nucl Med Mol Imaging, 2023, 50, 2591
DOI: 10.1007/s00259-023-06266-5

Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids

Qing-Bin Zhang, Si-Da Ruan, Yong Wu, Jin-Hua Zhang, Jian-Guang Lu and Jun Feng

Pharmaceutical Fronts, 2020, 02, e160
DOI: 10.1055/s-0041-1728817

Enantioresolution and Binding Affinity Studies on Human Serum Albumin: Recent Applications and Trends

Tony Cardoso, Ana Sofia Almeida, Fernando Remião and Carla Fernandes

Chemosensors, 2021, 9, 304
DOI: 10.3390/chemosensors9110304

Design and Biological Evaluation of the Long-Acting C5-Inhibited Ornithodoros moubata Complement Inhibitor (OmCI) Modified with Fatty Acid

Wenwen Shangguan, Xiaowan Li, Yandan Wang, Zongqing Huang, Yuanzhen Dong, Meiqing Feng and Jun Feng

Bioconjugate Chem., 2024, 35, 653
DOI: 10.1021/acs.bioconjchem.4c00126

Palmitic Acid-Conjugated Radiopharmaceutical for Integrin αvβ3-Targeted Radionuclide Therapy

Guangjie Yang, Hannan Gao, Chuangwei Luo, Xiaoyu Zhao, Qi Luo, Jiyun Shi and Fan Wang

Pharmaceutics, 2022, 14, 1327
DOI: 10.3390/pharmaceutics14071327

Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration

Siddharth Jindal, Dennis Vestergaard Pedersen, Nimish Gera, Julian Chandler, Rekha Patel, Alyssa Neill, Josh Cone, Yuchun Zhang, Chao-Xing Yuan, Ellen E. Millman, Dan Carlin, Bridget Puffer, Douglas Sheridan, Gregers Rom Andersen and Paul Tamburini

Molecular Immunology, 2024, 165, 29
DOI: 10.1016/j.molimm.2023.12.004

A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK Study

Lin-Zhi Chen, David Roos, Elsy Philip, Emily G. Werth, Stephanie Kostuk, Hongbin Yu and Holger Fuchs

Pharmaceuticals, 2024, 17, 193
DOI: 10.3390/ph17020193

Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy

Thomas S. C. Ng, Huiyu Hu, Stefan Kronister, Chanseo Lee, Ran Li, Luca Gerosa, Sylwia A. Stopka, Danielle M. Burgenske, Ishaan Khurana, Michael S. Regan, Sreeram Vallabhaneni, Niharika Putta, Ella Scott, Dylan Matvey, Anita Giobbie-Hurder, Rainer H. Kohler, Jann N. Sarkaria, Sareh Parangi, Peter K. Sorger, Nathalie Y. R. Agar, Heather A. Jacene, Ryan J. Sullivan, Elizabeth Buchbinder, Hannes Mikula, Ralph Weissleder and Miles A. Miller

Sci. Adv., 2022, 8
DOI: 10.1126/sciadv.abl6339

Synthesis of a Novel PTH1–34 Analog with Increased Human Serum Albumin Affinity

Si-Da Ruan, Yuan-Zhen Dong, Jian-Guang Lu, Meng-Jia Zhao, Wei-Gen Lu and Jun Feng

Pharmaceutical Fronts, 2021, 03, e23
DOI: 10.1055/s-0041-1731299

Combining Solid‐State NMR with Structural and Biophysical Techniques to Design Challenging Protein‐Drug Conjugates

Linda Cerofolini, Kristian Vasa, Elisa Bianconi, Maria Salobehaj, Giulia Cappelli, Alice Bonciani, Giulia Licciardi, Anna Pérez‐Ràfols, Luis Padilla‐Cortés, Sabrina Antonacci, Domenico Rizzo, Enrico Ravera, Caterina Viglianisi, Vito Calderone, Giacomo Parigi, Claudio Luchinat, Antonio Macchiarulo, Stefano Menichetti and Marco Fragai

Angewandte Chemie, 2023, 135
DOI: 10.1002/ange.202303202

Genetically encoded discovery of perfluoroaryl macrocycles that bind to albumin and exhibit extended circulation in vivo

Jeffrey Y. K. Wong, Arunika I. Ekanayake, Serhii Kharchenko, Steven E. Kirberger, Ryan Qiu, Payam Kelich, Susmita Sarkar, Jiaqian Li, Kleinberg X. Fernandez, Edgar R. Alvizo-Paez, Jiayuan Miao, Shiva Kalhor-Monfared, J. Dwyer John, Hongsuk Kang, Hwanho Choi, John M. Nuss, John C. Vederas, Yu-Shan Lin, Matthew S. Macauley, Lela Vukovic, William C. K. Pomerantz and Ratmir Derda

Nat Commun, 2023, 14
DOI: 10.1038/s41467-023-41427-y

Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron

Ivan S. Pires, François Berthiaume and Andre F. Palmer

Annu. Rev. Biomed. Eng., 2023, 25, 1
DOI: 10.1146/annurev-bioeng-081622-031203

Interaction of Positively Charged Oligopeptides with Blood Plasma Proteins

Aleksandra Kotynia, Aleksandra Marciniak, Wojciech Kamysz, Damian Neubauer and Edward Krzyżak

IJMS, 2023, 24, 2836
DOI: 10.3390/ijms24032836

Increased Valency Improves Inhibitory Activity of Peptides Targeting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

Benjamin J. Tombling, Carmen Lammi, Carlotta Bollati, Anna Anoldi, David J. Craik and Conan K. Wang

ChemBioChem, 2021, 22, 2154
DOI: 10.1002/cbic.202100103

A Single‐Stranded DNA‐Encoded Chemical Library Based on a Stereoisomeric Scaffold Enables Ligand Discovery by Modular Assembly of Building Blocks

Gabriele Bassi, Nicholas Favalli, Miriam Vuk, Marco Catalano, Adriano Martinelli, Anika Trenner, Antonio Porro, Su Yang, Chuin Lean Tham, Mustafa Moroglu, Wyatt W. Yue, Stuart J. Conway, Peter K. Vogt, Alessandro A. Sartori, Jörg Scheuermann and Dario Neri

Advanced Science, 2020, 7
DOI: 10.1002/advs.202001970

Prediction of Half-Life Extension of Peptides via Serum Albumin Binding: Current Challenges

Youssef Hijazi

Eur J Drug Metab Pharmacokinet, 2021, 46, 163
DOI: 10.1007/s13318-020-00664-y

Recent advances in albumin nanoparticle-based cancer therapies

Smala Shrestha, Amit Shrestha, Jeonghwan Kim, Raj Kumar Thapa and Jong Oh Kim

J. Pharm. Investig., 2025, 55, 1
DOI: 10.1007/s40005-024-00687-6

Molecular interaction study of flavonols with human serum albumin by theoretical simulations

Ting Fu, Yan Li, Huiying Chu, Ming Zou, Shanshan Liang, Yuebin Zhang, Xuan Zhang, Guohui Li and Ruoyu Wang

Journal of Biomolecular Structure and Dynamics, 2025, 1
DOI: 10.1080/07391102.2025.2467192

In Vivo Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin Binders

Julien C. Vantourout, Andrew M. Mason, Josephine Yuen, Graham L. Simpson, Ghotas Evindar, Letian Kuai, Michael Hobbs, Emma Edgar, Saul Needle, Xiaopeng Bai, Steve Wilson, Paul Scott-Stevens, William Traylen, Kim Lambert, Neil Young, Shenaz Bunally, Scott G. Summerfield, Richard Snell, Rakesh Lad, Eric Shi, Steven Skinner, Lisa Shewchuk, Allan J.B. Watson, Chun-wa Chung, Sandeep Pal, Dennis A. Holt, Lara S. Kallander, Joanne Prendergast, Katrina Rivera, David G. Washburn, Mark R. Harpel, Christopher Arico-Muendel and Albert Isidro-Llobet

Bioconjugate Chem., 2021, 32, 279
DOI: 10.1021/acs.bioconjchem.0c00662

Dendritic amphiphilic siRNA: Selective albumin binding, in vivo efficacy, and low toxicity

Hassan H. Fakih, Qi Tang, Ashley Summers, Minwook Shin, Julianna E. Buchwald, Rosemary Gagnon, Vignesh N. Hariharan, Dimas Echeverria, David A. Cooper, Jonathan K. Watts, Anastasia Khvorova and Hanadi F. Sleiman

Molecular Therapy Nucleic Acids, 2023, 34, 102080
DOI: 10.1016/j.omtn.2023.102080

Prolonged half-life of small-sized therapeutic protein using serum albumin-specific protein binder

Tae Yoon Kim, Jin Ho Park, Ha Eun Shim, Dae Seong Choi, Dong-Eun Lee, Ji-Joon Song and Hak-Sung Kim

Journal of Controlled Release, 2019, 315, 31
DOI: 10.1016/j.jconrel.2019.09.017

Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle

Javad Garousi, Emma von Witting, Jesper Borin, Anzhelika Vorobyeva, Mohamed Altai, Olga Vorontsova, Mark W. Konijnenberg, Maryam Oroujeni, Anna Orlova, Vladimir Tolmachev and Sophia Hober

Biomaterials, 2021, 266, 120381
DOI: 10.1016/j.biomaterials.2020.120381

Effect of Linker Entities on Pharmacokinetics of 111In-Labeled Prostate-Specific Membrane Antigen-Targeting Ligands with an Albumin Binder

Nobuki Kazuta, Kazuma Nakashima, Hiroyuki Watanabe and Masahiro Ono

ACS Pharmacol. Transl. Sci., 2024, 7, 2401
DOI: 10.1021/acsptsci.4c00257

Lymphatic targeting by albumin-hitchhiking: Applications and optimisation

Mohammad Abdallah, Olivia O. Müllertz, Ian K. Styles, Alexander Mörsdorf, John F. Quinn, Michael R. Whittaker and Natalie L. Trevaskis

Journal of Controlled Release, 2020, 327, 117
DOI: 10.1016/j.jconrel.2020.07.046

Effects of Human Serum Albumin on the Fluorescence Intensity and Tumor Imaging Properties of IR‐780 Dye

Lei Long, Xu Tan, Zujuan Liu, Yunsheng Liu, Xiaohui Cao and Chunmeng Shi

Photochem & Photobiology, 2022, 98, 935
DOI: 10.1111/php.13547

NANOG Decoy Oligodeoxynucleotide–Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells

Mahmoud Gharbavi, Behrooz Johari, Elham Rismani, Navid Mousazadeh, Amir Hossein Taromchi and Ali Sharafi

ACS Chem. Neurosci., 2020, 11, 4499
DOI: 10.1021/acschemneuro.0c00699

Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution

Carsten Höltke, Martin Grewer, Miriam Stölting, Christiane Geyer, Moritz Wildgruber and Anne Helfen

Mol. Pharmaceutics, 2021, 18, 2574
DOI: 10.1021/acs.molpharmaceut.1c00064

Human serum albumin binders: A piggyback ride for long-acting therapeutics

Aziz Ullah, Goeun Shin and Sung In Lim

Drug Discovery Today, 2023, 28, 103738
DOI: 10.1016/j.drudis.2023.103738

Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer

Tian Huan, Bugao Guan, Hongbo Li, Xiu Tu, Chi Zhang and Bin Tang

Human Vaccines & Immunotherapeutics, 2023, 19
DOI: 10.1080/21645515.2023.2256904

Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview

Bart Boersma, Hélène Poinot and Aurélien Pommier

Pharmaceutics, 2024, 16, 974
DOI: 10.3390/pharmaceutics16080974

Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers

Conor McQuaid, Andrea Halsey, Maëva Dubois, Ignacio Romero, David Male and Mária A. Deli

PLoS ONE, 2021, 16, e0252341
DOI: 10.1371/journal.pone.0252341

Carborane-containing amino acids and peptides: Synthesis, properties and applications

Dmitry A. Gruzdev, Galina L. Levit, Victor P. Krasnov and Valery N. Charushin

Coordination Chemistry Reviews, 2021, 433, 213753
DOI: 10.1016/j.ccr.2020.213753

In silico and multi-spectroscopic analyses on the interaction of 5-amino-8-hydroxyquinoline and bovine serum albumin as a potential anticancer agent

Waralee Ruankham, Kamonrat Phopin, Ratchanok Pingaew, Supaluk Prachayasittikul, Virapong Prachayasittikul and Tanawut Tantimongcolwat

Sci Rep, 2021, 11
DOI: 10.1038/s41598-021-99690-2

Diboronate Fluorophore for the Measurement of l-Glucose and Other Carbohydrates and Its Interaction with Albumin

Konstantinos Solomos, Victoria Tarus, Vladislav Kotek, Gaetano Invernizzi and Thomas Hoeg-Jensen

ACS Omega, 2022, 7, 24662
DOI: 10.1021/acsomega.2c02519

Anticandidal Activity of Lipopeptides Containing an LL-37-Derived Peptide Fragment KR12

Malgorzata Anna Paduszynska, Damian Neubauer, Wojciech Kamysz and Elzbieta Kamysz

Molecules, 2025, 30, 1598
DOI: 10.3390/molecules30071598

Non-immunoglobin scaffold binders as efficient affinity ligands for purification of broad-spectrum serum albumins

Hongyu Lu, Yunqing Sun, Jie Chen, Jing Li, Yuzhe Chen, Tingting Long, Tianshan She, Hong Zhu, Youmei Jin, Hao Yang, Xiaofeng Lu and Ze Tao

Talanta, 2025, 285, 127262
DOI: 10.1016/j.talanta.2024.127262

Design and evolution of a synthetic small protein scaffold based on the WW domain

Ana Margarida Gonçalves Carvalho Dias, Gonçalo Duarte Gomes Teixeira, Arménio Jorge Moura Barbosa, Joao Goncalves, Olga Iranzo and Ana Cecília Afonso Roque

Protein Science, 2025, 34
DOI: 10.1002/pro.70164

Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions

Sara Linciano, Giulia Moro, Alessandro Zorzi and Alessandro Angelini

Journal of Controlled Release, 2022, 348, 115
DOI: 10.1016/j.jconrel.2022.05.038

An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade

Hongchuan Liu, Rui Wang, Duopeng An, Hui Liu, Fan Ye, Baoxian Li, Jing Zhang, Peixiang Liu, Xuyao Zhang, Sheng Yao, Ziyang Zhong, Hui Feng and Meiqing Feng

International Immunopharmacology, 2021, 101, 108307
DOI: 10.1016/j.intimp.2021.108307

A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile

Wei Xu, Zhe Cong, Qianyu Duan, Qian Wang, Shan Su, Rui Wang, Lu Lu, Jing Xue and Shibo Jiang

Pharmaceuticals, 2022, 15, 424
DOI: 10.3390/ph15040424

Albumin-based drug designs for pharmacokinetic modulation

Diego Pilati and Kenneth A. Howard

Expert Opinion on Drug Metabolism & Toxicology, 2020, 16, 783
DOI: 10.1080/17425255.2020.1801633

Post-operative agranulocytosis caused by intravenous cefazolin: A case report with a discussion of the pathogenesis

Lombard Charles M, Li Jiali and Shrestha Bijayee

Arch Pathol Clin Res, 2022, 6, 009
DOI: 10.29328/journal.apcr.1001030

Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate

Elena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, Robert Dagil, Sai Sundar Rajan Raghavan, Lara Duvnjak, Mie Anemone Nordmaj, Thomas Mandel Clausen, Ann Skafte, Jan Oberkofler, Kaituo Wang, Mette Ø Agerbæk, Caroline Løppke, Amalie Mundt Jørgensen, Daria Ropac, Joana Mujollari, Shona Willis, Agnès Garcias López, Rebecca Louise Miller, Richard Torbjörn Gustav Karlsson, Felix Goerdeler, Yen-Hsi Chen, Ana R. Colaço, Yong Wang, Thomas Lavstsen, Agnieszka Martowicz, Irina Nelepcu, Mona Marzban, Htoo Zarni Oo, Maj Sofie Ørum-Madsen, Yuzhuo Wang, Morten A. Nielsen, Henrik Clausen, Michael Wierer, Dominik Wolf, Ismail Gögenur, Thor G. Theander, Nader Al-Nakouzi, Tobias Gustavsson, Mads Daugaard and Ali Salanti

Nat Commun, 2024, 15
DOI: 10.1038/s41467-024-51781-0

A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity

Praveen Praveen, Chao Wang, Thomas N. G. Handley, Hongkang Wu, Chrishan S. Samuel, Ross A. D. Bathgate and Mohammed Akhter Hossain

IJMS, 2023, 24, 6616
DOI: 10.3390/ijms24076616

Novel Radiotheranostic Ligands Targeting Prostate-Specific Membrane Antigen Based on Dual Linker Approach

Nobuki Kazuta, Kazuma Nakashima, Yuta Tarumizu, Takumi Sato, Yoshifumi Maya, Hiroyuki Watanabe and Masahiro Ono

Mol. Pharmaceutics, 2025, 22, 377
DOI: 10.1021/acs.molpharmaceut.4c00974

The Uniqueness of Albumin as a Carrier in Nanodrug Delivery

Alessandra Spada, Jaber Emami, Jack A. Tuszynski and Afsaneh Lavasanifar

Mol. Pharmaceutics, 2021, 18, 1862
DOI: 10.1021/acs.molpharmaceut.1c00046

Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases

Stefano Pluda, Ylenia Mazzocato and Alessandro Angelini

Front. Mol. Biosci., 2021, 8
DOI: 10.3389/fmolb.2021.703715

Protein Engineering Strategies for Improved Pharmacokinetics

Aurélie Rondon, Sohaib Mahri, Francisco Morales‐Yanez, Mireille Dumoulin and Rita Vanbever

Adv Funct Materials, 2021, 31
DOI: 10.1002/adfm.202101633

Albumin: An Emerging Opportunity in Drug Delivery

Parastou Rahimizadeh, Sungtae Yang and Sung In Lim

Biotechnol Bioproc E, 2020, 25, 985
DOI: 10.1007/s12257-019-0512-9

Mechanisms of GIP in inhibiting cancer growth: Updates and perspectives

Aixin Wang, Xinyu Ye, G.J. Mizejewski and Chao Zhang

International Journal of Pharmaceutics, 2025, 681, 125824
DOI: 10.1016/j.ijpharm.2025.125824

Navigating Between Right, Wrong, and Relevant: The Use of Mathematical Modeling in Preclinical Decision Making

Anna Kondic, Dean Bottino, John Harrold, Jeffrey D. Kearns, CJ Musante, Aleksandrs Odinecs, Saroja Ramanujan, Jangir Selimkhanov and Birgit Schoeberl

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.860881

Enhanced Binding Site Identification in Protein–Ligand Complexes with a Combined Blind Docking and Dipolar Electron Paramagnetic Resonance Approach

Mikhail Kolokolov, Natalya Sannikova, Sergei Dementev, Roman Podarov, Kseniya Zhdanova, Natal’ya Bragina, Alexey Chubarov, Matvey Fedin and Olesya Krumkacheva

J. Am. Chem. Soc., 2025, 147, 13677
DOI: 10.1021/jacs.5c01274

Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein

Lingxin Meng, Jianyang Fang, Liang Zhao, Tingting Wang, Pu Yuan, Zuoquan Zhao, Rongqiang Zhuang, Qin Lin, Haojun Chen, Xiaoyuan Chen, Xianzhong Zhang and Zhide Guo

J. Med. Chem., 2022, 65, 8245
DOI: 10.1021/acs.jmedchem.1c02162

Messenger RNA Expression of Albumin, Transferrin, Transthyretin, Asialoglycoprotein Receptor, Cytochrome P450 Isoform, Uptake Transporter, and Efflux Transporter Genes as a Function of Culture Duration in Prolonged Cultured Cryopreserved Human Hepatocytes as Collagen-Matrigel Sandwich Cultures: Evidence for Redifferentiation upon Prolonged Culturing

Qian Yang and Albert P. Li

Drug Metabolism and Disposition, 2021, 49, 790
DOI: 10.1124/dmd.121.000424

Albumin affibody-outfitted injectable gel enabling extended release of urate oxidase-albumin conjugates for hyperuricemia treatment

Jinhwan Cho, Seong Han Kim, Byungseop Yang, Jae Min Jung, Inchan Kwon and Doo Sung Lee

Journal of Controlled Release, 2020, 324, 532
DOI: 10.1016/j.jconrel.2020.05.037

Hypothesis of using albumin to improve drug efficacy in cancers accompanied by hypoalbuminemia

Soghra Bagheri and Ali A. Saboury

Xenobiotica, 2021, 51, 778
DOI: 10.1080/00498254.2021.1929557

Investigation of the Interaction between Human Serum Albumin and Branched Short-Chain Perfluoroalkyl Compounds

Giulia Moro, Stefano Liberi, Filippo Vascon, Sara Linciano, Sofia De Felice, Silvano Fasolato, Carlo Foresta, Luca De Toni, Andrea Di Nisio, Laura Cendron and Alessandro Angelini

Chem. Res. Toxicol., 2022, 35, 2049
DOI: 10.1021/acs.chemrestox.2c00211

An Affibody Molecule Is Actively Transported into the Cerebrospinal Fluid via Binding to the Transferrin Receptor

Sebastian W. Meister, Linnea C. Hjelm, Melanie Dannemeyer, Hanna Tegel, Hanna Lindberg, Stefan Ståhl and John Löfblom

IJMS, 2020, 21, 2999
DOI: 10.3390/ijms21082999

Fluorene methoxycarbonyl-PEG-deferoxamine conjugates “hitchhike” with albumin in situ for iron overload therapy

Linyi Xu, Rou Guan, Bohong Yu, Yicheng Li, Hongzhuo Liu and Yiguo Jiang

International Journal of Pharmaceutics, 2022, 625, 122136
DOI: 10.1016/j.ijpharm.2022.122136

Combining Solid‐State NMR with Structural and Biophysical Techniques to Design Challenging Protein‐Drug Conjugates

Linda Cerofolini, Kristian Vasa, Elisa Bianconi, Maria Salobehaj, Giulia Cappelli, Alice Bonciani, Giulia Licciardi, Anna Pérez‐Ràfols, Luis Padilla‐Cortés, Sabrina Antonacci, Domenico Rizzo, Enrico Ravera, Caterina Viglianisi, Vito Calderone, Giacomo Parigi, Claudio Luchinat, Antonio Macchiarulo, Stefano Menichetti and Marco Fragai

Angew Chem Int Ed, 2023, 62
DOI: 10.1002/anie.202303202

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials

Tsutomu Takeuchi, Yukihiro Chino, Masafumi Kawanishi, Megumi Nakanishi, Hirotaka Watase, Yoko Mano, Yuri Sato, Saeko Uchida and Yoshiya Tanaka

Arthritis Res Ther, 2023, 25
DOI: 10.1186/s13075-023-03036-4

Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension

Jason Shirian, Alexandra Hockla, Justyna J. Gleba, Matt Coban, Naama Rotenberg, Laura M. Strik, Aylin Alasonyalilar Demirer, Matt L. Pawlush, John A. Copland, Evette S. Radisky and Julia M. Shifman

Biomolecules, 2024, 14, 1187
DOI: 10.3390/biom14091187

Single-chain tandem macrocyclic peptides as a scaffold for growth factor and cytokine mimetics

Kenichiro Ito, Yoshihiko Matsuda, Ayako Mine, Natsuki Shikida, Kazutoshi Takahashi, Kyohei Miyairi, Kazutaka Shimbo, Yoshimi Kikuchi and Atsushi Konishi

Commun Biol, 2022, 5
DOI: 10.1038/s42003-022-03015-6

Albumin binding Nanofitins, a new scaffold to extend half-life of biologics – a case study with exenatide peptide

Nadine Michot, Aurélia Guyochin, Mathieu Cinier, Chloé Savignard, Olivier Kitten, Marie-Hélène Pascual, Stéphanie Pouzieux, Marie-Laure Ozoux, Patrick Verdier, Pascale Vicat and Jacques Dumas

Peptides, 2022, 152, 170760
DOI: 10.1016/j.peptides.2022.170760

Impact of conjugation to different lipids on the lymphatic uptake and biodistribution of brush PEG polymers

Mohammad Abdallah, Lihuan Lin, Ian K. Styles, Alexander Mörsdorf, James L. Grace, Gracia Gracia, Cornelia B. Landersdorfer, Cameron J. Nowell, John F. Quinn, Michael R. Whittaker and Natalie L. Trevaskis

Journal of Controlled Release, 2024, 369, 146
DOI: 10.1016/j.jconrel.2024.03.032

Serum Albumin for Magnetic Nanoparticles Coating

Alexey S. Chubarov

Magnetochemistry, 2022, 8, 13
DOI: 10.3390/magnetochemistry8020013

Application of Elastin-like Polypeptide in Tumor Therapy

Xianggang Shi, Dongfeng Chen, Guodong Liu, Hailing Zhang, Xiaoyan Wang, Zhi Wu, Yan Wu, Feng Yu and Qinggang Xu

Cancers, 2022, 14, 3683
DOI: 10.3390/cancers14153683

Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview

Rohit Sharma, Shishu K. Suman and Archana Mukherjee

CMC, 2022, 29, 5979
DOI: 10.2174/0929867329666220607160559

Interactions of N-Mannich Bases of Pyrrolo[3,4-c]pyrrole with Artificial Models of Cell Membranes and Plasma Proteins, Evaluation of Anti-Inflammatory and Antioxidant Activity

Łukasz Szczukowski, Jadwiga Maniewska, Benita Wiatrak, Paulina Jawień, Edward Krzyżak, Aleksandra Kotynia, Aleksandra Marciniak, Maciej Janeczek and Aleksandra Redzicka

Membranes, 2023, 13, 349
DOI: 10.3390/membranes13030349

Progress of albumin-polymer conjugates as efficient drug carriers

Radhika Raveendran, You Dan Xu, Nidhi Joshi and Martina H. Stenzel

Pure and Applied Chemistry, 2022, 94, 983
DOI: 10.1515/pac-2021-2006

Half‐life extension of single‐domain antibody–drug conjugates by albumin binding moiety enhances antitumor efficacy

Quanxiao Li, Yu Kong, Yuxuan Zhong, Ailing Huang, Tianlei Ying and Yanling Wu

MedComm, 2024, 5
DOI: 10.1002/mco2.557

Diverse Roles of Antibodies in Antibody–Drug Conjugates

Aiko Yamaguchi and H. Charles Manning

Pharmaceuticals, 2025, 18, 180
DOI: 10.3390/ph18020180

Albumin-based strategies to effectively prolong the circulation half-life of small immunomodulatory payloads in cancer therapy

Sara Linciano, Emilia Vigolo, Antonio Rosato, Yoichi Kumada and Alessandro Angelini

Current Opinion in Biotechnology, 2024, 90, 103218
DOI: 10.1016/j.copbio.2024.103218

The emerging landscape of peptide-based inhibitors of PCSK9

Benjamin J. Tombling, Yuhui Zhang, Yen-Hua Huang, David J. Craik and Conan K. Wang

Atherosclerosis, 2021, 330, 52
DOI: 10.1016/j.atherosclerosis.2021.06.903

Ozoralizumab: first Nanobody® therapeutic for rheumatoid arthritis

Yoshiya Tanaka

Expert Opinion on Biological Therapy, 2023, 23, 579
DOI: 10.1080/14712598.2023.2231344

Interactions of hydrophobically modified hyaluronan carrier with bovine serum albumin

Frantisek Ondreas, Jaroslav Sita, Martin Cepa, Eliska Svecova and Vladimir Velebny

Applied Surface Science, 2022, 593, 153440
DOI: 10.1016/j.apsusc.2022.153440

Development of new albumin-binding radiotracers for PET imaging of cerebrospinal fluid flow in the glymphatic system

Martta Peltoniemi, Surachet Imlimthan, Sonja C. Jalonen, Niklas Daniel Åke Persson, Terhi J. Lohela, Tuomas O. Lilius and Mirkka Sarparanta

EJNMMI radiopharm. chem., 2025, 10
DOI: 10.1186/s41181-025-00365-4

Bioconjugation Techniques for Enhancing Stability and Targeting Efficiency of Protein and Peptide Therapeutics

Tanuja Bisht, Anupriya Adhikari, Shivanand Patil and Shivang Dhoundiyal

CPPS, 2024, 25, 226
DOI: 10.2174/0113892037268777231013154850

Conjugates for use in peptide therapeutics: A systematic review and meta-analysis

Ashan Wijesinghe, Sarika Kumari, Valerie Booth and Aldrin V. Gomes

PLoS ONE, 2022, 17, e0255753
DOI: 10.1371/journal.pone.0255753

A Comparison of Evans Blue and 4-(p-Iodophenyl)butyryl Albumin Binding Moieties on an Integrin αvβ6 Binding Peptide

Ryan A. Davis, Sven H. Hausner, Rebecca Harris and Julie L. Sutcliffe

Pharmaceutics, 2022, 14, 745
DOI: 10.3390/pharmaceutics14040745

Detailed cellular assessment of albumin-bound oligonucleotides: Increased stability and lower non-specific cell uptake

Aurélie Lacroix, Hassan H. Fakih and Hanadi F. Sleiman

Journal of Controlled Release, 2020, 324, 34
DOI: 10.1016/j.jconrel.2020.04.020